Polymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer

Cancer Biology and Therapy

Volumn 12, Issue 5, 2011, Pages 383-387

  Wang, Xiuchao ^a   Liu, Yingwei ^b   Ren, He ^a   Yuan, Zhanna ^a   Li, Shasha ^a   Sheng, Jun ^a   Zhao, Tiansuo ^a   Chen, Yong ^a   Liu, Fenghua ^a   Wang, Feng ^c   Huang, He ^b   Hao, Jihui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN UNIVERSITY   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CA19 9; Hypoxia inducible factor 1 (HIF 1 ); Pancreatic cancer; Pancreatic ductal adenocarcinoma (PDAC); Single nucleotide polymorphism (SNP)

Indexed keywords

CA 19-9 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STAINING; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052354214     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.5.15982     Document Type: Article

References (22)

1. Wang G.L., Jiang B.H., Rue E.A., Semenza GL. Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92:5510-4; PMID: 7539918; DOI: 10.1073/pnas.92.12.5510.
2. Carroll V.A., Ashcroft M. Targeting the molecular basis for tumour hypoxia. Expert Rev Mol Med 2005; 7:1-16; PMID: 15831177; DOI: 10.1017/ S1462399405009117.
3. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med 2004; 36:1-12; PMID: 15031665.
4. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxiainducible factor-1α in common human cancers and their metastases. Cancer Res 1999; 59:5830-5835; PMID: 10582706.
5. Koong A.C., Mehta V.K., Le Q.T., Fisher G.A., Terris D.J., Brown J.M., et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 2000; 48:919-22; PMID: 11072146; DOI: 10.1016/S0360- 3016(00)00803-8.
6. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., et al. Modulation of hypoxiainducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol-3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60:1541-1545; PMID: 10749120.
7. Hoffmann A.C., Mori R., Vallbohmer D., Brabender J., Klein E., Drebber U., et al. High expression of HIF1α is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF and bFGF. Neoplasia 2008; 10:674-679; PMID: 18592007.
8. Kitada T., Seki S., Sakaguchi H., Sawada T., Hirakawa K., Wakasa K. Clinicopathological significance of hypoxiainducible factor-1α expression in human pancreatic carcinoma. Histopathology 2003; 43:550-5; PMID: 14636255; DOI: 10.1111/j.1365-2559.2003.01733.x.
9. Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, Ko S, et al. Prognostic significance of HIF-1α overexpression in human pancreatic cancer. Anticancer Res 2003; 23:4721-4727; PMID: 14981919.
10. Couvelard A., O'Toole D., Leek R., Turley H., Sauvanet A., Degott C., et al. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology 2005; 46:668-76; PMID:15910598; DOI: 10.1111/j.1365-2559.2005. 02160.x.
11. Sun H.C., Qiu Z.J., Liu J., Sun J., Jiang T., Huang K.J., et al. Expression of hypoxia-inducible factor-1α and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol 2007; 30:1359-1367; PMID: 17487356.
12. Cheng B.Q., Segersvärd R., Permert J., Wang F. Pancreatic cancer cells expressing hypoxia-inducible factor-1α tend to be adjacent to intratumoral blood vessels. Eur Surg Res 2010; 45:134-7; PMID: 20924188; DOI: 10.1159/000319876.
13. Tanimoto K., Yoshiga K., Eguchi H., Kaneyasu M., Ukon K., Kumazaki T., et al. Hypoxia-inducible factor- 1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003; 24:1779-83; PMID: 12919954; DOI: 10.1093/carcin/bgg132.
14. Jiang B.H., Zheng J.Z., Leung S.W., Roe R., Semenza GL. Transactivation and inhibitory domains of hypoxiainducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 1997; 272:19253-60; PMID: 9235919; DOI: 10.1074/ jbc.272.31.19253.
15. Fu X.S., Choi E., Bubley G.J., Balk SP. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 2005; 63:215-21; PMID: 15538748; DOI: 10.1002/ pros.20190.
16. Chen M.K., Chiou H.L., Su S.C., Chung T.T., Tseng H.C., Tsai H.T., et al. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol 2009; 45:222- 6; PMID: 19717330; DOI: 10.1016/j.oraloncology. 2009.07.015.
17. Hsiao P.C., Chen M.K., Su S.C., Ueng K.C., Chen Y.C., Hsieh Y.H., et al. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 2010; 102:163- 9; PMID: 20648588; DOI: 10.1002/jso.21539.
18. Naidu R., Har Y.C., Taib NA. Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer. Neoplasma 2009; 56:441-7; PMID: 19580347; DOI: 10.4149/neo-2009-05-441.
19. Knechtel G., Szkandera J., Stotz M., Hofmann G., Langsenlehner U., Krippl P., et al. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog 2010; 49:805-809; PMID: 20572162.
20. Fransén K., Fenech M., Fredrikson M., Dabrosin C., Söderkvist P. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 2006; 45:833- 40; PMID: 16865676; DOI: 10.1002/mc.20209.
21. Barton J.G., Bois J.P., Sarr M.G., Wood C.M., Qin R., Thomsen K.M., et al. Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. J Gastrointest Surg 2009; 13:2050-8; PMID: 19756875; DOI: 10.1007/s11605-009-0849-z.
22. Muñoz-Guerra M.F., Fernández-Contreras M.E., Moreno A.L., Martín I.D., Herráez B., Gamallo C. Polymorphisms in the hypoxia inducible factor-1alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 2009; 16:2351-8; PMID: 19449077; DOI: 10.1245/s10434-009-0503-8.